Brinks Hofer Gilson & Lione Opens Office in Salt Lake City; Adds Key Talent to Its Biotech/Pharma Group
Posted on: Tuesday, 18 July 2006, 15:00 CDT
CHICAGO, July 18 /PRNewswire/ -- Brinks Hofer Gilson & Lione, one of the largest intellectual property law firms in the U.S., announces the opening of a Salt Lake City office, coinciding with the hiring of two former Holland & Hart IP attorneys, Christopher L. Wight and Ryan L. Marshall. The new Salt Lake City office will be headed by veteran Brinks shareholder, Steven P. Shurtz.
"Brinks is a world leader in the areas of chemical, biotech and pharma IP and already serves a solid client base in the Intermountain West," said Shurtz. "With the addition of these two outstanding attorneys, we are increasing the firm's depth in these areas and building on service excellence to clients in this region."
The new Salt Lake City office is located at 299 S. Main Street, Suite 1300, Salt Lake City, telephone (801) 355-7900; Fax (801) 355-7901, http://www.usebrinks.com/.
Steven P. Shurtz has been a part of Brinks since 1983. He specializes in U.S. patent application preparation and prosecution and is experienced in supervising patent procurement activities, including foreign patent strategies, oppositions and the use of the Patent Cooperation Treaty as well as preparing and prosecuting patent applications on individual chemical and mechanical inventions. He also has experience in patent infringement/validity and right to use opinions and license agreements; trade secrets audits, analysis and agreements; and training seminars for client employees. Mr. Shurtz received his law degree from the S.J. Quinney College of Law at the University of Utah and his B.S degree in Chemical Engineering from the University of Utah. Mr. Shurtz can be reached at sshurtz@usebrinks.com.
Christopher L. Wight began his career in intellectual property law at Brinks in 1985. After three years, he left Brinks to join Immunex Corporation, an internationally recognized biotechnology company located in Seattle, Washington, where he eventually served as Director of Intellectual Property. Among his responsibilities, Mr. Wight prepared and prosecuted patents relating to numerous biologic products, including Enbrel(R), now a $2 billion a year product marketed by Amgen. After leading Immunex's in-house biotech practice for 10 years, Mr. Wight joined Myriad Genetics, a genomics and proteomics company located in Salt Lake City, Utah, where he served for four years as Vice President and General Counsel. Mr. Wight's practice will continue to focus on strategic counseling, as well as preparing, prosecuting and evaluating U.S. and foreign patents, in the biotechnology and pharmaceutical fields. He received his law degree from the J. Reuben Clark Law School at Brigham Young University and his undergraduate degree in Chemistry, also from Brigham Young University. Mr. Wight can be reached at cwight@usebrinks.com.
Ryan L. Marshall joins Brinks as an associate with expertise in a broad range of chemical technologies, including pharmaceuticals, cosmetics, drug delivery, organic synthesis, laboratory instrumentation, waste remediation, chemical sensors, propellants, explosives and pollution control chemistry. Mr. Marshall's experience also includes seven years of bench chemistry, instrumental methods and data analysis in organic chemistry. His academic research focused on lipid A analogues and mechanisms for inhibiting septic shock. Mr. Marshall received his law, Master's (organic chemistry) and undergraduate degrees from Brigham Young University. Mr. Marshall can be reached at rmarshall@usebrinks.com.
Founded in 1917, Brinks Hofer Gilson & Lione is based in Chicago with four other offices across the country serving the intellectual property needs of clients from around the world. The firm is one of the largest IP law firms in the country, with more than 150 attorneys, scientific advisors and patent agents specializing in intellectual property litigation and all aspects of patent, trademark, copyright, trade secret, unfair competition, intellectual asset management, and technology and licensing agreements. Brinks routinely handles assignments in fields as diverse as electrical, chemical, mechanical, biotechnology, pharmaceutical, nanotechnology, Internet and computer technology, as well as in trademarks or brand names for a wide variety of products and services. For additional information, visit http://www.usebrinks.com/.
CONTACT: Sydney Iglitzen (312) 840-3163 siglitzen@usebrinks.com
Brinks Hofer Gilson & Lione
CONTACT: Sydney Iglitzen of Brinks Hofer Gilson & Lione,+1-312-840-3163, or siglitzen@usebrinks.com
Web site: http://www.usebrinks.com/
Source: PRNewswire
Related Articles
- The Practising Law Institute's Patent Center Will Provide Live Coverage of the Bilski Supreme Court Hearing
- ECOtality's Dr. Jerry Y.S. Lin Appointed Chair of the Department of Chemical Engineering at Arizona State University
- TapImmune Inc. Announces Acquisition of Core TAP Technologies and Intellectual Property From The University of British Columbia; New Name to Reflect a New Direction and Independent Operation
- Delta Rounds Out Summer Expansion With More Flights At Los Angeles, New York City, Salt Lake City; Summer Schedule Offers Customers Access to 21 New Worldwide Destinations
- MLS: Kansas City 3, Salt Lake City 3
- Cook Group Partners With Indiana University School of Law to Create Innovative Intellectual Property Internship
- Parliament backs new EU law on toxic chemicals
- EU parliament backs new law on toxic chemicals
- Report: Lethal Chemicals Close to Cities; Officials Fear Terrorists Could Target Plants
- Lumera Awarded Fifth Patent; New Intellectual Property Centers on Improved Photostability for Optical Components
 |
 |
User Comments (0)
RSS Feeds